Transforming growth factor-β1 in the cerebrospinal fluid of patients with distinct neurodegenerative diseases

详细信息    查看全文

• 作者：Tomoyuki Masuda^a ; ^b ; ¹ ; Junko Itoh^b ; ¹ ; Takuya Koide^b ; ¹ ; Yasushi Tomidokoro^b ; Yosuke Takei^c ; Kazuhiro Ishii^b ; ^{kazishii@md.tsukuba.ac.jp} ; Akira Tamaoka^b
• 关键词：Neurodegenerative disease ; Multiple system atrophy ; Spinocerebellar degeneration ; Amyotrophic lateral sclerosis ; Cerebrospinal fluid ; Transforming growth factor-β1
• 刊名：Journal of Clinical Neuroscience
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：35
• 期：Complete
• 页码：47-49
• 全文大小：249 K
• 卷排序：35

文摘

We measured TGF-β1 in the CSF of patients with ALS, SCD, and MSA-C. We found that these TGF-β1 levels were not different from normal controls. TGF-β1 in the CSF is an unreliable biomarker of ALS, SCD, and MSA-C.